Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non–Small Cell Lung CancerYoshimasa Shiraishi, Isamu Okamoto, Kazumi Nishino et al.|JAMA Oncology|2023Cited by 52
HSP27 modulates epithelial to mesenchymal transition of lung cancer cells in a Smad-independent mannerHideaki Mizutani, Akihiko Gemma|Oncology Letters|2010Cited by 30
First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1Makoto Nishio, Hideaki Mizutani, Yuichiro Ohe et al.|International Journal of Clinical Oncology|2023Cited by 13
Study Design and Rationale for Marble Study: A Phase II Trial of Atezolizumab (MPDL3280A) Plus Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Thymic Carcinoma (JTD2101)Tetsuhiko Asao, Kazuhisa Takahashi, Takehito Shukuya et al.|Clinical Lung Cancer|2023Cited by 5